| dc.contributor.author | Chamorro Fernández, Antonio Javier | |
| dc.contributor.author | Casado, J. L. | |
| dc.contributor.author | Bellido, D. | |
| dc.contributor.author | Moreno Guillén, Santiago | |
| dc.date.accessioned | 2024-01-08T11:38:10Z | |
| dc.date.available | 2024-01-08T11:38:10Z | |
| dc.date.issued | 2005-07-01 | |
| dc.identifier.citation | Chamorro, A. J., Casado, J. L., Bellido, D., & Moreno, S. (2005). Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. European Journal of Clinical Microbiology and Infectious Diseases, 24, 492-494. https://doi.org/10.1007/s10096-005-1355-1 | es_ES |
| dc.identifier.issn | 0934-9723 | |
| dc.identifier.uri | http://hdl.handle.net/10366/154040 | |
| dc.description.abstract | [EN]Presented here is the first report of clinical reactivation of hepatitis B virus (HBV) in an HIV-infected patient
who previously had anti-HBc as the only serological marker
of past infection (anti-HBc alone). Reactivation occurred
after lamivudine was removed from the patient’s antiretroviral treatment regimen due to lack of virological response.
HIV-infected patients frequently present anti-HBc alone,
and in some cases this serological profile is associated with
occult HBV infection. The current case demonstrates the
importance of ruling out the possibility of occult infection
in this patient group | en_EN |
| dc.language.iso | eng | es_ES |
| dc.publisher | Springer | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.rights.uri | http://creativecommons.org/publicdomain/zero/1.0/ | * |
| dc.subject | Hepatitis B | |
| dc.subject.mesh | Hepatitis B | * |
| dc.subject.mesh | HIV Antibodies | * |
| dc.subject.mesh | Hepatitis B e Antigens | * |
| dc.title | Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.1007/s10096-005-1355-1 | |
| dc.identifier.doi | 10.1007/s10096-005-1355-1 | |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | es_ES |
| dc.identifier.essn | 1435-4373 | |
| dc.journal.title | European Journal of Clinical Microbiology & Infectious Diseases | en_EN |
| dc.volume.number | 24 | es_ES |
| dc.issue.number | 7 | es_ES |
| dc.page.initial | 492 | es_ES |
| dc.page.final | 494 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | hepatitis B | * |
| dc.subject.decs | antigenos E de la hepatitis B | * |
| dc.subject.decs | anticuerpos VIH | * |